Azellon is a spin-out company from The University of Bristol focused on the development and commercialisation of a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair - the Cell Bandage.
The first application of Cell Bandage under development is the repair of tears of the avascular (white) zone knee meniscus, a growing market with unmet needs.
INFORMATION FOR MEMBERS OF THE PUBLIC INTERESTED IN THE CELL BANDAGE TREATMENT
Azellon is currently conducting a Phase I/IIa clinical trial in Bristol, UK. Recruitment for the trial is expected to be complete in the second half of 2013 with preliminary results due in 2014.
If you would like any additional information about Cell Bandage please contact Professor Anthony Hollander: A.Hollander@azellonctx.com
What is meniscal tissue? All joints have a thin layer of cartilage at the ends of the bones where they meet each other to prevent the bones from fracturing and to allow a smooth movement of the joint. more
How is meniscal tissue injured? The menisci are commonly torn as a result of a sporting injury. The lateral meniscus (on the outside edge of the knee) is most frequently injured although the medial meniscus (on the inside edge) may also sometimes be damaged. more
How might stem cells be used to repair torn meniscal tissue? Azellon's meniscal repair technology will combine your own bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. more
What are adult stem cells and where do they come from? Adult stem cells are found in all of us. They are non-specialised cells that can grow extensively and can be turned into many different kinds of specialised cell. The specialised cells help to maintain the different organs of our body. more